Korean Drug Co., Ltd. (KOSDAQ:014570)
South Korea
· Delayed Price · Currency is KRW 4,950.00
-10.00 (-0.20%)
At close: Jun 18, 2025, 3:30 PM KST
Korean Drug Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 447.34 | 2,995 | -4,917 | 11,809 | 9,042 | 7,360 | Upgrade
|
| Depreciation & Amortization | 2,044 | 2,069 | 1,749 | 1,383 | 1,470 | 1,355 | Upgrade
|
| Loss (Gain) From Sale of Assets | -8.67 | -3.56 | 3.68 | -2.81 | -1.13 | 5.28 | Upgrade
|
| Loss (Gain) From Sale of Investments | 24.9 | -72.9 | -132.87 | 383.6 | 359.46 | 1,534 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | - | 576.86 | Upgrade
|
| Provision & Write-off of Bad Debts | -140.49 | - | - | - | - | - | Upgrade
|
| Other Operating Activities | -1,188 | -513.96 | 2,118 | -801.33 | 1,384 | 1,491 | Upgrade
|
| Change in Accounts Receivable | 9,112 | 4,806 | 3,566 | -1,390 | -948.64 | 872.88 | Upgrade
|
| Change in Inventory | -62.96 | -1,605 | -4,657 | -971.78 | -2,149 | 1,030 | Upgrade
|
| Change in Accounts Payable | -2,167 | -1,351 | 1,916 | -3,208 | 550.5 | -403.67 | Upgrade
|
| Change in Other Net Operating Assets | 2,977 | -1,455 | -1,645 | -1,288 | -900.83 | -1,492 | Upgrade
|
| Operating Cash Flow | 11,037 | 4,869 | -1,999 | 5,913 | 8,806 | 12,330 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -32.86% | -28.58% | 98.60% | Upgrade
|
| Capital Expenditures | -884.14 | -1,027 | -120.7 | -6,093 | -1,146 | -738.47 | Upgrade
|
| Sale of Property, Plant & Equipment | 7.47 | 7.46 | 1.12 | 5.86 | 4.5 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -17.62 | -15.71 | -466.7 | -384.22 | 157.73 | 219.04 | Upgrade
|
| Investment in Securities | -10,162 | -9,830 | 18,159 | 894.66 | -6,980 | -9,911 | Upgrade
|
| Other Investing Activities | 0.28 | -23.96 | -5,299 | 175 | -291 | 140 | Upgrade
|
| Investing Cash Flow | -11,056 | -10,889 | 12,274 | -5,401 | -8,254 | -10,290 | Upgrade
|
| Long-Term Debt Repaid | - | -88.34 | -82.46 | -76.55 | -75.69 | -81.97 | Upgrade
|
| Total Debt Repaid | -93.66 | -88.34 | -82.46 | -76.55 | -75.69 | -81.97 | Upgrade
|
| Net Debt Issued (Repaid) | -93.66 | -88.34 | -82.46 | -76.55 | -75.69 | -81.97 | Upgrade
|
| Issuance of Common Stock | 128.54 | 133.7 | 18.31 | 3.61 | 24.01 | 10.01 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -1,103 | - | Upgrade
|
| Dividends Paid | -1,730 | -1,618 | -1,941 | -1,833 | -1,634 | -1,089 | Upgrade
|
| Other Financing Activities | -0 | - | - | 0 | 0 | - | Upgrade
|
| Financing Cash Flow | -1,695 | -1,573 | -2,005 | -1,906 | -2,789 | -1,161 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.87 | 6.89 | -7.09 | -20.35 | 10.95 | -81.16 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | 0 | 0 | - | -0 | Upgrade
|
| Net Cash Flow | -1,712 | -7,586 | 8,263 | -1,415 | -2,227 | 797.4 | Upgrade
|
| Free Cash Flow | 10,153 | 3,842 | -2,119 | -180.15 | 7,660 | 11,592 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -33.92% | 267.27% | Upgrade
|
| Free Cash Flow Margin | 15.20% | 5.26% | -2.60% | -0.22% | 10.29% | 17.36% | Upgrade
|
| Free Cash Flow Per Share | 944.22 | 356.01 | -196.53 | -16.71 | 701.12 | 1066.91 | Upgrade
|
| Cash Interest Paid | 5.08 | 4.24 | 3.02 | 2.1 | 1.53 | 3.13 | Upgrade
|
| Cash Income Tax Paid | 3,887 | 3,792 | 12,140 | 3,383 | 2,274 | 840.74 | Upgrade
|
| Levered Free Cash Flow | 10,601 | 3,630 | 7,388 | -2,709 | 6,243 | 9,411 | Upgrade
|
| Unlevered Free Cash Flow | 10,604 | 3,632 | 7,390 | -2,707 | 6,244 | 9,413 | Upgrade
|
| Change in Net Working Capital | -8,754 | -40.43 | -2,029 | 6,569 | 1,279 | -1,678 | Upgrade
|
Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.